1 results match your criteria: "Klinikum Bad Bramstedt and University Medical Center Schleswig-Holstein[Affiliation]"
Treatment failure by canakinumab in a patient with progressive multisystemic Erdheim-Chester disease refractory to anakinra: successful use of vemurafenib.
Rheumatology (Oxford)
October 2015
Vasculitis Center, Department of Rheumatology and Clinical Immunology, Klinikum Bad Bramstedt and University Medical Center Schleswig-Holstein, Bad Bramstedt and.